PLG anticorps (AbBy Fluor® 594)
-
- Antigène Voir toutes PLG Anticorps
- PLG (Plasminogen (PLG))
-
Reactivité
- Humain, Souris, Rat
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp PLG est conjugé à/à la AbBy Fluor® 594
-
Application
- Western Blotting (WB)
- Réactivité croisée
- Humain
- Homologie
- Mouse,Rat,Dog,Cow,Pig
- Purification
- Purified by Protein A.
- Immunogène
- KLH conjugated synthetic peptide derived from human PLG
- Isotype
- IgG
- Top Product
- Discover our top product PLG Anticorps primaire
-
-
- Indications d'application
- IF(IHC-P) 1:50-200
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- Date de péremption
- 12 months
-
- Antigène
- PLG (Plasminogen (PLG))
- Autre désignation
- Plasminogen (PLG Produits)
- Synonymes
- anticorps wu:fb70e09, anticorps PLG, anticorps LPA, anticorps plg, anticorps Ab1-346, anticorps AI649309, anticorps Pg, anticorps plasminogen, anticorps plg, anticorps PLG, anticorps Plg
- Sujet
-
Synonyms: Plasminogen, Angiostatin, DKFZp779M0222, Microplasmin, Plasmin, Plasmin heavy chain A, PLG, PLMN_HUMAN.
Background: Plasminogen is a plasma protein synthesised mostly in the liver. Plasma concentration is usually in the range of 70 to 200 mg/l. Plasminogen is activated by tissue plasminogen activator, urokinase and streptokinase, to form plasmin. Activation results from the cleavage and release of the preactivation peptide. Angiostatin, an internal fragment of plasminogen, is a potent inhibitor of angiogenesis, which selectively inhibits endothelial cell proliferation. Angiostatin potently inhibits tumor growth and can maintain metastatic and primary tumors in a dormant state. It is defined by a balance of proliferation and apoptosis of the tumor cells and is composed of plasminogen first four cringle structures. This molecule is generated by proteolytic cleavage of plasminogen.
- ID gène
- 5340
- UniProt
- P00747
- Pathways
- Système du Complément, Lipid Metabolism
-